Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) obtained the "Drug Registration Certificate" for Saku Polbuxartan Nabbesartan Tablets.

Zhichuan Financial News APP, Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) announced that Shandong Xinhua Pharmaceutical Co., Ltd. (hereinafter referred to as "Xinhua Pharmaceutical" or "the Company") recently received the "Drug Registration Certificate" for Sacubitril Valsartan Sodium Tablets (hereinafter referred to as "the Product") approved and issued by the National Medical Products Administration.